RANKL treatment releases the negative regulation of the poly(ADP-ribose) polymerase-1 on Tcirg1 gene expression during osteoclastogenesis

Journal of Bone and Mineral Research

Volumn 21, Issue 11, 2006, Pages 1757-1769

  Beranger, Guillaume E ^a   Momier, David ^a   Rochet, Nathalie ^a   Quincey, Danielle ^a   Guigonis, Jean Marie ^a   Samson, Michel ^b   Carle, Georges F ^a   Scimeca, Jean Claude ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b INSERM   (France)

Author keywords

Infantile malignant osteopetrosis; Osteoclast; Poly(ADP ribose) polymerase 1; RANKL; Tcirg1 promoter

Indexed keywords

MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NUCLEAR PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; SMALL INTERFERING RNA;

ALBERS SCHOENBERG DISEASE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; CROSS LINKING; ENZYME SUBUNIT; GEL MOBILITY SHIFT ASSAY; GENE; GENE DELETION; GENE EXPRESSION REGULATION; GENE LOCUS; GENE MUTATION; GENE REPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; OSTEOCLASTOGENESIS; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; TCIRG1 GENE; TRANSCRIPTION INITIATION SITE; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; CELL NUCLEUS; GENE EXPRESSION REGULATION; MICE; MOLECULAR SEQUENCE DATA; OSTEOCLASTS; POLY(ADP-RIBOSE) POLYMERASES; PROMOTER REGIONS (GENETICS); RANK LIGAND; RNA, MESSENGER; TRANSCRIPTION, GENETIC; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 33846441715     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.060809     Document Type: Article

References (56)

1. Boyle WJ, Simonet WS, Lacey DL 2003 Osteoclast differentiation and activation. Nature 423:337-342.
2. Harada S, Rodan GA 2003 Control of osteoblast function and regulation of bone mass. Nature 423:349-355.
3. Francis MJ, Lees RL, Trujillo E, Martin-Vasallo P, Heersche JN, Mobasheri A 2002 ATPase pumps in osteoclasts and osteoblasts. Int J Biochem Cell Biol 34:459-476.
4. Manolson MF, Proteau D, Preston RA, Stenbit A, Roberts BT, Hoyt MA, Preuss D, Mulholland J, Botstein D, Jones EW 1992 The VPII1 gene encodes a 95-kDa integral membrane polypeptide required for in vivo assembly and activity of the yeast vacuolar H(+)-ATPase. J Biol Chem 267:14294-14303.
5. Manolson MF, Wu B, Proteau D, Taillon BE, Roberts BT, Hoyt MA, Jones EW 1994 STV1 gene encodes functional homologue of 95-kDa yeast vacuolar H(+)-ATPase subunit Vph1p. J Biol Chem 269:14064-14074.
6. Leng XH, Manolson MF, Liu Q, Forgac M 1996 Site-directed mutagenesis of the 100-kDa subunit (Vphl p) of the yeast vacuolar (H-)-ATPase. J Biol Chem 271:22487-22493.
7. Landolt-Marticorena C, Kahr WH, Zawarinski P, Correa J, Manolson MF 1999 Substrate- and inhibitor-induced conformational changes in the yeast V-ATPase provide evidence for communication between the catalytic and proton-translocating sectors. J Biol Chem 274:26057-26064.
8. Landolt-Marticorena C, Williams KM, Correa J, Chen W, Manolson MF 2000 Evidence that the NH2 terminus of vph1p, an integral subunit of the V0 sector of the yeast V-ATPase, interacts directly with the Vma1p and Vma13p subunits of the V1 sector. J Biol Chem 275:15449-15457.
9. Mattsson JP, Li X, Peng SB, Nilsson F, Andersen P, Lundberg LG, Stone DK, Keeling DJ 2000 Properties of three isoforms of the 116-kDa subunit of vacuolar H+-ATPase from a single vertebrate species. Cloning, gene expression and protein characterization of functionally distinct isoforms in Gallus gallus. Eur J Biochem 267:4115-4126.
10. Nishi T, Forgac M 2000 Molecular cloning and expression of three isoforms of the 100-kDa a subunit of the mouse vacuolar proton-translocating ATPase. J Biol Chem 275:6824-6830.
11. Toyomura T, Oka T, Yamaguchi C, Wada Y, Futai M 2000 Three subunit a isoforms of mouse vacuolar H(+)-ATPase. Preferential expression of the a3 isoform during osteoclast differentiation. J Biol Chem 275:8760-8765.
12. Oka T, Murata Y, Namba M, Yoshimizu T, Toyomura T, Yamamoto A, Sun-Wada GH, Hamasaki N, Wada Y, Futai M 2001 a4, a unique kidney-specific isoform of mouse vacuolar H+-ATPase subunit a. J Biol Chem 276:40050-40054.
13. Manolson MF, Yu H, Chen W, Yao Y, Li K, Lees RL, Heersche JN 2003 The a3 isoform of the 100-kDa V-ATPase subunit is highly but differentially expressed in large (>or = 10 nuclei) and small (
14. Scimeca JC, Franchi A, Trojani C, Parrinello H, Grosgeorge J, Robert C, Jaillon O, Poirier C, Gaudray P, Carle GF 2000 The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone 26:207-213.
15. Li YP, Chen W, Liang Y, Li E, Stashenko P 1999 Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat Genet 23:447-451.
16. Frattini A, Orchard PJ, Sobacchi C, Giliani S, Abinun M, Mattsson JP, Keeling DJ, Andersson AK, Wallbrandt P, Zecca L, Notarangelo LD, Vezzoni P, Villa A 2000 Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet 25:343-346.
17. Kornak U, Schulz A, Friedrich W, Uhlhaas S, Kremens B, Voit T, Kasan C, Bode U, Jentsch TJ, Kubisch C 2000 Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum Mol Genet 9:2059-2063.
18. Michigami T, Kageyama T, Satomura K, Shima M, Yamaoka K, Nakayama M, Ozono K 2002 Novel mutations in the a3 subunit of vacuolar H(+)-adenosine triphosphatase in a Japanese patient with infantile malignant osteopetrosis. Bone 30:436-439.
19. Scimeca JC, Quincey D, Parrinello H, Romatet D, Grosgeorge J, Gaudray P, Philip N, Fischer A, Carle GF 2003 Novel mutations in the TCIRG1 gene encoding the a3 subunit of the vacuolar proton pump in patients affected by infantile malignant osteopetrosis. Hum Mutat 21:151-157.
20. Susani L, Pangrazio A, Sobacchi C, Taranta A, Mortier G, Savarirayan R, Villa A, Orchard P, Vezzoni P, Albertini A, Frattini A, Pagani F 2004 TCIRG1-dependent recessive osteopetrosis: Mutation analysis, functional identification of the splicing defects, and in vitro rescue by U1 snRNA. Hum Mutat 24:225-235.
21. Heinemann T, Bulwin GC, Randall J, Schnieders B, Sandhoff K, Volk HD, Milford E, Gullans SR, Utku N 1999 Genomic organization of the gene coding for TIRC7, a novel membrane protein essential for T cell activation. Genomics 57:398-406.
22. Utku N, Heinemann T, Tullius SG, Bulwin GC, Beinke S, Blumberg RS, Beato F, Randall J, Kojima R, Busconi L, Robertson ES, Schulein R, Volk HD, Milford EL, Gullans SR 1998 Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein. Immunity 9:509-518.
23. Deng W, Stashenko P, Chen W, Liang Y, Shimizu K, Li YP 2001 Characterization of mouse Atp6i gene, the gene promoter, and the gene expression. J Bone Miner Res 16:1136-1146.
24. Adereth Y, Champion KJ, Hsu T, Dammai V 2005 Site-directed mutagenesis using Pfu DNA polymerase and T4 DNA ligase. Biotechniques 38:864-868.
25. Liu Y, Shi Z, Silveira A, Liu J, Sawadogo M, Yang H, Feng X 2003 Involvement of upstream stimulatory factors 1 and 2 in RANKL-induced transcription of tartrate-resistant acid phosphatase gene during osteoclast differentiation. J Biol Chem 278:20603-20611.
26. Tezuka K, Nemoto K, Tezuka Y, Sato T, Ikeda Y, Kobori M, Kawashima H, Eguchi H, Hakeda Y, Kumegawa M 1994 Identification of matrix metalloproteinase 9 in rabbit osteoclasts. J Biol Chem 269:15006-15009.
27. Wagner EF 2002 Functions of API (Fos/Jun) in bone development. Ann Rheum Dis 61(Suppl 2):ii40-ii42.
28. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T 2002 Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3:889-901.
29. Tondravi MM, McKercher SR, Anderson K, Erdmann JM, Quiroz M, Maki R, Teitelbaum SL 1997 Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 386:81-84.
30. Palmqvist P, Lundberg P, Persson E, Johansson A, Lundgren I, Lie A, Conaway HH, Lerner UH 2005 Inhibition of hormone and cytokine stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased OPG and decreased RANKL and RANK in a STAT6 dependent pathway. J Biol Chem. 281:2414-2429.
31. Saltman LH, Javed A, Ribadeneyra J, Hussain S, Young DW, Osdoby P, Amcheslavsky A, van Wijnen AJ, Stein JL, Stein GS, Lian JB, Bar-Shavit Z 2005 Organization of transcriptional regulatory machinery in osteoclast nuclei: Compartmentalization of Runx1. J Cell Physiol 204:871-880.
32. Yu Z, Kuncewicz T, Dubinsky WP, Kone BC 2006 Nitric oxide-dependent negative feedback of PARP-1 trans-activation of the inducible nitric-oxide synthase gene. J Biol Chem 281:9101-9109.
33. Kaufmann SH 1989 Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: A cautionary note. Cancer Res 49:5870-5878.
34. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG 1993 Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res 53:3976-3985.
35. Purnell MR, Whish WJ 1980 Novel inhibitors of poly(ADP-ribose) synthetase. Biochem J 185:775-777.
36. Blair HC, Robinson LJ, Zaidi M 2005 Osteoclast signalling pathways. Biochem Biophys Res Commun 328:728-738.
37. Matsumoto M, Kogawa M, Wada S, Takayanagi H, Tsujimoto M, Katayama S, Hisatake K, Nogi Y 2004 Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. J Biol Chem 279:45969-45979.
38. Shi Z, Silveira A, Patel P, Feng X 2004 YY1 is involved in RANKL-induced transcription of the tartrate-resistant acid phosphatase gene in osteoclast differentiation. Gene 343:117-126.
39. D'Amours D, Desnoyers S, D'Silva I, Poirier GG 1999 Poly(ADP-ribosyl) ation reactions in the regulation of nuclear functions. Biochem J 342:249-268.
40. Kim MY, Zhang T, Kraus WL 2005 Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal. Genes Dev 19:1951-1967.
41. Hassa PO, Hottiger MO 2002 The functional role of poly(ADP-ribose) polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders. Cell Mol Life Sci 59:1534-1553.
42. Kraus WL, Lis JT 2003 PARP goes transcription. Cell 113:677-683.
43. Nirodi C, NagDas S, Gygi SP, Olson G, Aebersold R, Richmond A 2001 A role for poly(ADP-ribose) polymerase in the transcriptional regulation of the melanoma growth stimulatory activity (CXCLl) gene expression. J Biol Chem 276:9366-9374.
44. Zhang Z, Hildebrandt EF, Simbulan-Rosenthal CM, Anderson MG 2002 Sequence-specific binding of poly(ADP-ribose) polymerase-1 to the human T cell leukemia virus type-I tax responsive element. Virology 296:107-116.
45. Huang K, Tidyman WE, Le KU, Kirsten E, Kun E, Ordahl CP 2004 Analysis of nucleotide sequence-dependent DNA binding of poly(ADP-ribose) polymerase in a purified system. Biochemistry 43:217-223.
46. Chiba-Falek O, Kowalak JA, Smulson ME, Nussbaum RL 2005 Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene. Am J Hum Genet 76:478-492.
47. Potaman VN, Shlyakhtenko LS, Oussatcheva EA, Lyubchenko YL, Soldatenkov VA 2005 Specific binding of poly(ADP-ribose) polymerase-1 to cruciform hairpins. J Mol Biol 348:609-615.
48. Soldatenkov VA, Chasovskikh S, Potaman VN, Trofimova I, Smulson ME, Dritschilo A 2002 Transcriptional repression by binding of poly(ADP-ribose) polymerase to promoter sequences. J Biol Chem 277:665-670.
49. Valverde P, Tu Q, Chen J 2005 BSP and RANKL induce osteoclastogenesis and bone resorption synergistically. J Bone Miner Res 20:1669-1679.
50. Kamada S, Kikkawa U, Tsujimoto Y, Hunter T 2005 Nuclear translocation of caspase-3 is dependent on its proteolytic activation and recognition of a substrate-like protein(s). J Biol Chem 280:857-860.
51. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC 1994 Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346-347.
52. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL, Miller DK 1995 Identification and inhibition of the ICE/ CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43.
53. Germain M, Affar EB, D'Amours D, Dixit VM, Salvesen GS, Poirier GG 1999 Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7. J Biol Chem 274:28379-28384.
54. Gobeil S, Boucher CC, Nadeau D, Poirier GG 2001 Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): Implication of lysosomal proteases. Cell Death Differ 8:588-594.
55. Blair HC, Sidonio RF, Friedberg RC, Khan NN, Dong SS 2000 Proteinase expression during differentiation of human osteoclasts in vitro. J Cell Biochem 78:627-637.
56. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, Ignatieva EV, Ananko EA, Podkolodnaya OA, Kolpakov FA, Podkolodny NL, Kolchanov NA 1998 Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26:362-367.